Inventor · disambiguated record
Jingyi Xiang
Also filed as: XIANG JINGYI
12 granted patents·8 pending applications·62 citations·filing 2009–2022
89Inventor score
Files withEUREKA THERAPEUTICS INC9MEMORIAL SLOAN KETTERING CANCER CENTER5LIU CHENG3INVISISHIELD TECH LTD2FIVE PRIME THERAPEUTICS INC1
Top patents by PatentIndex Score
20 records- 0195US11155615B2Anti-ROR1 antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Oct 26, 2021·13 cites·13 claims
- 0292US10011658B2Constructs targeting AFP peptide/MHC complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Jul 3, 2018·14 cites·24 claims
- 0389US11440952B2Compositions for preventing or treating viral and other microbial infectionsINVISISHIELD TECH LTD·Filed 2021·Granted Sep 13, 2022·3 cites·22 claims
- 0488US10239952B2Anti-WT1/HLA bi-specific antibodyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2014·Granted Mar 26, 2019·8 cites·8 claims
- 0585US8080415B2Modified host cells and uses thereofLIU CHENG·Filed 2009·Granted Dec 20, 2011·8 cites·11 claims
- 0685US8025879B2Modified glycoproteins and uses thereofEUREKA THERAPEUTICS INC·Filed 2009·Granted Sep 27, 2011·7 cites·6 claims
- 0782US11117964B2Anti-KIR3DL1 antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Sep 14, 2021·4 cites·20 claims
- 0880US8084222B2Methods for generating host cellsLIU CHENG·Filed 2009·Granted Dec 27, 2011·4 cites·13 claims
- 0976US11447564B2Constructs specifically recognizing glypican 3 and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Sep 20, 2022·1 cites·25 claims
- 1070US12479924B2Constructs specifically recognizing Glypican 3 and uses thereofEUREKA THERAPEUTICS INC·Filed 2022·Granted Nov 25, 2025·0 cites·27 claims
- 1169US2021277117A1Constructs targeting afp peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1262US11168150B2T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLAMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Nov 9, 2021·0 cites·16 claims
- 1362US2023141962A1Compositions for preventing or treating viral and other microbial infectionsINVISISHIELD TECH LTD·Filed 2022·Application pending·0 cites
- 1457US2018009892A1Anti-ror1 antibodiesEUREKA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1552US2012107874A1Modified Host Cells and Uses ThereofLIU CHENG·Filed 2011·Application pending·0 cites
- 1648US2016369006A1Fc-ENHANCED ANTI-WT1/HLA ANTIBODYMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2014·Application pending·0 cites
- 1748US2018208658A1Constructs targeting afp peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1846US10501559B2T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLAMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Dec 10, 2019·0 cites·28 claims
- 1939US2020087400A1Constructs targeting psa peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2037US2019382504A1Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jingyi Xiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →